IL-6 has also been implicated in JIA and JDM (11, 17, 84, 85) and is used in polyarticular, extended oligoarticular, systemic JIA (49), and refractory JDM (50), but mechanistic studies in pediatric disease are lacking. Here, IL6 is linked to juvenile dermatomyositis.